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Abstract 1 
Background and Objectives: Intermittent claudication (IC) is the most common symptom 2 
of peripheral arterial disease, which significantly affects walking ability, functional capacity 3 
and quality of life. Supervised exercise programmes (SEP) are recommended as first line 4 
treatment, but recruitment and adherence rates are poor. The time required to complete a SEP 5 
is the most common barrier to participation cited by patients who decline.  High-intensity 6 
interval training (HIIT) is more time efficient than current SEP’s and therefore has the 7 
potential to overcome this barrier.  8 
We conducted a systematic review to appraise the evidence for HIIT programmes for IC.  9 
Data Sources and Review Methods: MEDLINE, Embase and CENTRAL databases were 10 
searched for terms related to HIIT and IC. Randomised and non-randomised trials that 11 
investigated HIIT for the treatment of IC were included, with no exclusions based on exercise 12 
modality, protocol or use of a comparator arm. Outcome measures were walking distances, 13 
peak oxygen uptake, recruitment and adherence rates and quality of life. Risk of bias was 14 
assessed using the Cochrane tool and study quality using a modified PEDro scale. 15 
Results: 9 articles reporting 8 studies were included in the review. HIIT appears to improve 16 
walking distances and oxygen uptake in relation to controls, with improvements attainable in 17 
just 6 weeks. When HIIT was compared to low-intensity exercise, it appeared that longer 18 
low-intensity programmes were required to obtain similar benefits to those from short-term 19 
HIIT.  20 
Conclusion: Initial evidence suggests that HIIT may provide benefits for IC patients. 21 
initially, pilot studies of low-volume, short-term HIIT versus usual SEP’s are required. This 22 
will allow for larger randomised controlled trials to be appropriately designed and adequately 23 
powered   to further explore the potential benefits of HIIT in IC. 24 
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Introduction 1 
Peripheral arterial disease (PAD) occurs when arteriosclerosis reduces the blood supply to the 2 
lower limbs1. PAD is common with global prevalence estimates of 10-20% in the population 3 
> 70 years2. Intermittent claudication (IC), the most common symptom of PAD, is a 4 
reproducible cramping, ischaemic muscle pain precipitated by exertion and relieved by rest3, 5 
4. IC often significantly impairs walking ability, functional capacity and quality of life (QoL), 6 
and is associated with an increased mortality risk3, 5-8.  7 
 8 
In the UK, the National Institute of Health and Clinical Excellence (NICE) recommend 9 
cardiovascular risk management and a supervised exercise programme (SEP) as the first-line 10 
treatment for IC.  The SEP should include a minimum of 2 hours / week of supervised 11 
exercise for a 12 week period, whereby patients are encouraged to walk to the point of 12 
maximal pain9. The evidence for SEP’s for IC is conclusive.  A recent Cochrane review 13 
clearly demonstrated significant improvements in both pain-free and maximum walking 14 
distances10. However, SEP design is relatively poorly reported which limits  replication and 15 
guideline development11. Furthermore, SEP recruitment and completion rates vary, but can 16 
be as low as 30% and 75% respectively and only 42% of NHS vascular units have access to a 17 
SEP12, 13. Clearly, there is the need to develop a more universally acceptable SEP for IC.  18 
 19 
High-intensity interval training (HIIT) results in similar or superior physical fitness benefits 20 
and is more time efficient than lower-intensity alternatives in both healthy and clinical 21 
populations e.g. coronary artery disease patients14-19.  22 
 23 
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Therefore, the aim of this review is to appraise the current evidence base to assess the 1 
acceptability and efficacy of HIIT as a treatment modality for patients with IC. An additional 2 
aim of this review is to provide standards that could be adopted for future HIIT studies. 3 
Methods 4 
A systematic review, adopting the Preferred Reporting Items for Systematic Reviews and 5 
Meta-Analyses (PRISMA) guidelines20, of randomised and non-randomised clinical trials 6 
assessing HIIT as a treatment for IC was performed.  7 
 8 
Search Strategy 9 
The search was conducted from database inception to February 2018 using the MEDLINE, 10 
Embase, and CENTRAL databases. Only full-text articles published in English and relating 11 
to adults (>18 years old) were included. Titles and abstracts were independently screened for 12 
inclusion by two reviewers (S.P. and J.P.) and any disagreement resolved by a third (A.E.H.). 13 
Full texts of any potentially eligible articles were then independently screened against the 14 
inclusion criteria. Reference lists of identified studies were also hand searched for other 15 
relevant papers. Search terms included “Intermittent claudication” [OR] “Peripheral Arterial 16 
Disease” [AND] “High intensity interval training” [OR] “HIIT” [OR] “High intensity 17 
exercise”, the full search strategy is shown in appendix 1. 18 
 19 
Inclusion Criteria 20 
We included both randomised and prospective non-randomised studies that investigated HIIT 21 
in patients diagnosed with IC (Fontaine II/Rutherford 1-3). Studies that included patients with 22 
asymptomatic PAD were excluded. Similar to a recent systematic review in the cardiac 23 
population, HIIT was defined as an interval approach conducted at ≥85% peak heart rate 24 
(HRPeak) or another surrogate measure (i.e. ≥80% maximal exercise capacity or peak 25 
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oxygen uptake [VO2Peak] or a rating of perceived exertion ≥15)21. There was no exclusion 1 
based on programme duration, frequency, protocol (i.e. ratio between length of exercise and 2 
rest periods) or the use of a comparator arm.  3 
 4 
Data Extraction 5 
Data extraction was performed using a standardised form and inputted into Microsoft Excel 6 
(Microsoft, 2010, Redmond, WA, USA). The data extraction included information on study 7 
characteristics (to assess quality), sample size, inclusion/exclusion criteria, intervention 8 
components, outcome measures and main findings. The primary outcome measure was 9 
maximum walking distance or time (MWD/T), and secondary measures included pain-free 10 
walking distance or time (PFWD/T), QoL, VO2Peak and recruitment and adherence rates. For 11 
key outcome measures, such as walking distance and VO2Peak (where reported appropriately), 12 
mean difference (MD) and between group effect sizes (ES) were calculated and adjusted for 13 
small sample-sizes using Hedges bias-correction 22. These effect sizes were interpreted as 14 
small (≥0.20 - <0.50), moderate (≥0.50 - <0.80) and large (≥0.80) 23. Where necessary, study 15 
authors were contacted for more information to allow computation of effect sizes. 16 
 17 
Risk of Bias 18 
Studies were independently assessed by two reviewers (S.P and J.P) using the Cochrane 19 
Collaboration tool 24. This consists of three-grades; low, unclear or high risk of bias. 20 
Disagreement was resolved by discussion or by a third reviewer (A.E.H).  21 
 22 
Quality Assessment 23 
Quality assessment was conducted using a modified version of the Physiotherapy Evidence 24 
Database (PEDro) scale. The PEDro scale awards a score out of 10 based on criteria 25 
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described elsewhere 25. As supervision is considered a vital element of exercise programmes 1 
for IC this was added as an extra quality criterion as previously described 26, leading to a total 2 
score out of 11 26, 27. 3 
 4 
Results 5 
Search Results 6 
The search yielded a total of 2023 results. A total of nine articles 28-36, reporting eight studies, 7 
were ultimately included in this review as shown in figure 1.  8 
 9 
Included Trials 10 
Trails included compared outcomes between HIIT and a low-intensity SEP or between HIIT 11 
and an “unsupervised” control group who were medically managed and given exercise advice 12 
without any supervised exercise intervention. 13 
 14 
Two studies compared HIIT with low-intensity exercise 31, 33, two included three arms and 15 
investigated two HIIT groups versus an unsupervised control group 28-30. Of the remaining 16 
studies, one included high-intensity resistance training versus low-intensity resistance 17 
training versus an unsupervised control group 32, and the other three compared HIIT to an 18 
unsupervised control group 34-36.  Studies are summarised in table I.  19 
 20 
The total number of recruited patients within the studies was 350. HIIT programmes varied 21 
widely between studies and included treadmill walking 31, 33, 34, 36, upper limb or lower limb 22 
cycling 28, 30, plantar flexion 35 or resistance training 32. The frequency, intensity and duration 23 
of programmes also varied and were generally completed 2-3 times per week for 12 to 40 24 
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minutes per session, for a period of six weeks to six months. HIIT intensity also ranged from 1 
80% to 100% of maximal workload achieved at baseline.  2 
 3 
All but one study included walking distance as an outcome measure. However, reporting was 4 
not consistent with the expression of walking distance in either meters or seconds. Maximal 5 
distance  was also measured via various testing methods including a graded treadmill 6 
protocol 31, 34-36, the incremental shuttle walk test 28, 30, or the six-minute walk test 32. The one 7 
study that did not include walking measurements reported time-to-exhaustion from a 8 
treadmill test 33. However, the authors did not state whether exhaustion constituted maximum 9 
claudication pain, therefore this study was not included in the analysis of walking distances.    10 
VO2Peak was included in six studies and measured via graded 31, 34-36 or stepwise rank 33 11 
treadmill tests, or a cycle ergometer 28, 30.  12 
 13 
Generic and disease-specific QoL was reported in three studies 28, 29, 31, using a combination 14 
of the Medical Outcomes Study Short-Form 36 (SF-36) and the walking impairment 15 
questionnaire (WIQ).  16 
Follow-up ranged from six to 72 weeks and intention-to-treat analysis was used in only one 17 
study 29, 30.  18 
 19 
Quality assessment and risk of bias 20 
Risk of bias summary is shown in figure 2 and study quality in table II. The mean score on 21 
the PEDro scale was 5.67 ± 1.41. In all studies there was a lack of allocation concealment, 22 
limited blinding of outcome assessors and patients and / or limited use of intention-to-treat 23 
analysis. Future studies could benefit from adopting bias reduction methods such as using a 24 
central allocation system and ensuring that outcome assessors are blinded to the allocated 25 
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 
International License. 
9 
treatment groups. In addition, when these methods are adopted, it is imperative that they are 1 
appropriately reported. 2 
Due to the limited number of studies, no publication bias assessment was made.  3 
 4 
Walking Performance 5 
Maximum walking distance or time (MWD/T) 6 
Three trials reported MWD in meters 28, 30, 32 and three trials reported MWT in seconds 34-36. 7 
The results suggest that all modes of exercise significantly improved MWD/T. Two trials 8 
reporting the effect of upper and lower limb HIIT on MWD demonstrated significant 9 
improvements from baseline (both p = <0.05) 28, 30, with one of these studies reporting that 10 
the changes were significantly greater than controls 30. For two trials reporting treadmill 11 
HIIT, both demonstrated significant improvements in MWT (p = <0.05). The improvement 12 
reported by Helgerud et al (2009) was significantly greater than the unsupervised control 13 
group, with moderate ES (p = <0.05, MD = 200s, ES = 0.60) 34. Wood et al (2006) 14 
demonstrated a 45% improvement but this did not reach statistical significance versus the 15 
unsupervised control group (p = 0.059, MD = 220s, ES = 0.31) 36. Wang et al (2008) reported 16 
the effect of plantar flexion HIIT on MWT and demonstrated a significant improvement 17 
versus baseline (p = 0.009), which was also significantly greater than controls (p = <0.05, 18 
MD = 173s, ES = 0.53) 35. Finally, Parmenter et al (2013) reported the effect of a resistance-19 
based HIIT programme on MWD and demonstrated a significant improvement versus 20 
baseline (p = 0.05), which was also significantly greater than the control group (p = 0.009, 21 
MD = 69.8m, ES = 0.74) 32. Full detail in table I.  22 
 23 
Gardner et al (2005) reported the effect of a 6-month high versus low-intensity treadmill 24 
programme on MWD and showed that both groups had significant improvements in MWD (p 25 
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= <0.01), and the change was similar between groups (p = >0.05; MD = 14m, ES = 0.06, 1 
favours high intensity; table I) 31. Parmenter et al (2013) also reported the effect of a high 2 
versus low-intensity resistance-based programme on MWD 32, with the HIIT group 3 
demonstrating a significant improvement (p = 0.05), whilst the lower intensity group had a 4 
reduction of -12% (between group MD = 68.7m, ES = 0.53, difference in change between 5 
groups p = 0.002) 32.  6 
 7 
Pain free walking distance or time (PFWD/T) 8 
Three trials reported PFWD in meters 28, 30, 32, and one trial reported PFWT in seconds 36. The 9 
results from two trials suggest that both upper and lower limb HIIT significantly improve 10 
PFWD (both p = <0.01) 28, 30, with one study reporting that the change was significantly 11 
greater than an unsupervised control group. The remaining study reporting PFWD 12 
demonstrated a non-significant increase following resistance-based HIIT 32. For the one study 13 
reporting PFWT following treadmill-based HIIT, there was a non-significant improvement 14 
following the exercise programme 36. The two non-significant findings may have been 15 
affected by the small samples given that the effect sizes for each training group versus control 16 
were large (MD = 121.9m, ES = 1.32) and moderate (MD = 150s, ES = 0.60) respectively. 17 
 18 
Two trials also reported PFWD for HIIT versus a low-intensity group (table I) 31, 32. A six 19 
month resistance-based programme elicited a 77% improvement in the HIIT group and a 2% 20 
reduction in the low-intensity group. The improvement in the HIIT group was not significant, 21 
nor was it significantly greater than the low-intensity group. However, this may have been 22 
effected by the small samples as there was a moderate effect size (0.58, MD = 80.2) 32. 23 
Finally, a six month treadmill programme elicited significant improvements in both groups (p 24 
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= <0.01), with the magnitude of change being similar between groups (p = >0.05, MD = 24m, 1 
ES = 0.18, favouring high-intensity). 2 
  3 
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Peak oxygen uptake (VO2peak) 1 
Four studies reported the effect of a HIIT programme on VO2Peak versus a control group 2 
(table I) 30, 34-36. A six month upper or lower limb cycling HIIT training programme improved 3 
VO2Peak compared to unsupervised controls (both p = <0.01), in both exercising groups 30. An 4 
eight week plantar flexion HIIT programme resulted in a 12% increase in VO2Peak (p = 0.002 5 
versus baseline and <0.05 versus control, MD = 2.4 ml·kg-1·min-1 ;ES = 0.54) in the training 6 
group 35. Two studies utilised a treadmill HIIT protocol with equivocal results. Following six 7 
weeks of HIIT treadmill training, there was a non-significant increase in VO2Peak in the 8 
exercise group (p = 0.069), with a small ES (0.18, MD = 1 ml·kg-1·min-1) 36. However, an 9 
eight week treadmill programme resulted in a significant (10%) improvement in VO2Peak (p = 10 
<0.05 versus baseline and controls, MD = 2.8 ml·kg-1·min-1, ES = 0.59) 34. 11 
 12 
Two studies also reported the effect of HIIT or low-intensity exercise on VO2Peak (table I) 31, 13 
33. An eight week treadmill HIIT programme resulted in a significantly greater improvement 14 
in VO2Peak, compared to the low-intensity group (16% versus 9%, p = <0.05). In contrast, a 15 
six month programme induced significant changes in VO2Peak for both groups (p = <0.05), 16 
and the between-group change was similar (p = >0.05, MD = 0.2 ml·kg-1·min-1 ES = 0.05 17 
favouring low-intensity).  18 
 19 
Quality of life 20 
Two studies of upper and lower limb cycling HIIT used the SF-36 questionnaire to assess 21 
QoL versus a control group 28-30. Following a six week programme, there were significant 22 
improvements in physical functioning and role limitation physical domains (p = <0.05) for 23 
both exercise groups, with no changes occurring in the other six domains. There were also no 24 
changes in any domain in the control group 28. Following 24 weeks of training, there was a 25 
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significant mean difference in the upper limb cycling group versus the control group for the 1 
vitality, general health, physical functioning, bodily pain and mental health domains (p = 2 
<0.05), with no changes in the other 3 domains 29, 30.  Conversely, the lower limb cycling 3 
group only demonstrated a significant mean difference in relation to controls for the vitality 4 
and general health domains, with no changes in the other six domains. These significant 5 
mean differences were maintained at 72 week follow-up with the exception of the 6 
improvement in vitality scores in the lower limb group.  7 
 8 
Zwierska et al (2005) also used the WIQ; with both exercise groups demonstrating significant 9 
improvement compared to the control group after 24 weeks in the domains of calf pain, 10 
walking speed and stair climbing. The upper limb group also demonstrated a significant 11 
improvement compared to controls in the domain of walking distance, which was not 12 
apparent in the lower limb group 29, 30. These improvements were not maintained at 72 week 13 
follow-up in the lower limb group, but were maintained for stair climbing and walking 14 
distance domains in the upper limb group 29. Full detail in table I. 15 
 16 
Recruitment and adherence 17 
One study reported the number of patients screened to allow for calculation of recruitment 18 
rate, which was approximately 20% 29. Completion rates were mostly in the region of 80-19 
90%, with one study reporting a slightly lower rate of 70% and two reporting 100%. 20 
Adherence rates were also reported in the majority of studies and were generally >90%. One 21 
study reported rates that were slightly lower at 74-80% 31, whilst one study reported that the 22 
participants in the exercise group completed all planned training sessions 35.  23 
 24 
Effect of programme duration and modality 25 
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The HIIT programmes varied in duration between trials, ranging from 6 weeks to 6 months, 1 
providing differing levels of improvement.  2 
Two six week programmes elicited improvements of between 61-122% and 32-50% in 3 
PFWD/PFWT and MWD/MWT respectively 28, 36. Two 8 week HIIT trials reported 4 
improvements of ∼15% in MWT but did not report PFWT 34, 35. The remaining trials adopted 5 
six month programmes and elicited improvements of between 51-109% and 19-63% in 6 
PFWD/PFWT and MWD/MWT respectively30-32.  7 
Benefits were also obtainable from a number of modalities with improvements in 8 
PFWD/PFWT and MWD/MWT ranging from 57-93% and 31-50% following lower limb 9 
cycling respectively 51-122% and 29-47% following upper limb cycling respectively, 61-10 
109% and 15-63% following treadmill walking respectively and 77% and 19% following 11 
resistance training respectively. Plantar flexion HIIT also resulted in a 16% improvement in 12 
MWT. 13 
 14 
Discussion 15 
Recent evidence supports the effectiveness of HIIT in a number of clinical populations 14-17. 16 
This review aimed to appraise the evidence base for HIIT as a treatment option for IC and 17 
provide standards for future HIIT studies in this population. Although the evidence base was 18 
limited, these preliminary results show that HIIT improves a number of important outcomes 19 
in patients with IC including walking distances, VO2Peak and QoL. 20 
 21 
Improvements in walking distances 22 
All studies that compared HIIT to a control group demonstrated significant improvements in 23 
MWD/T 28, 30, 32, 34-36, with changes occurring in as little as six weeks 28, 36. In addition, the 24 
majority of studies demonstrated significantly greater improvements than the control group, 25 
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with moderate between-group effect sizes 32, 34, 35. Only two studies considered HIIT versus a 1 
low-intensity exercise group, however, one adopted a resistance only based programme, 2 
which is not routinely used for SEP’s in the IC population 32. The other study compared a 6 3 
month high versus low-intensity walking programme, similar to that adopted in most SEP’s, 4 
with both groups demonstrating similar improvements in walking distances 31.   5 
 6 
These results perhaps demonstrate that although low-intensity programmes do elicit 7 
comparable changes in walking distance, the six month duration of the programme suggests 8 
this may be gradual and takes longer than a high-intensity course of exercise, which elicited 9 
improvements in just six weeks 31, 36. However, no trial has considered the effect of shorter 10 
term HIIT and low-intensity exercise programmes.  11 
A key benefit of HIIT, as these results demonstrate, is that it may be more time efficient, thus 12 
benefitting both patients (reducing the burden of attending sessions) and providers (cost 13 
reduction). These results suggest that HIIT can provide the same benefit to walking distances 14 
in half the amount of time currently recommended by UK guidelines 36.  15 
 16 
Peak Oxygen Uptake (VO2peak) 17 
VO2Peak is considered to be the gold standard measure of cardiorespiratory fitness 37, and is a 18 
strong independent predictor of all-cause mortality 38, 39. The results suggest that a HIIT 19 
programme can elicit significant improvements in VO2Peak, that are also superior in 20 
comparison to controls 30, 34, 35. One study however, did not reach statistical significance for 21 
the improvement VO2Peak with a mean difference of 1 ml·kg-1·min-1 36. Although this mean 22 
difference appears small, it may still be clinically meaningful. In a cohort study of cardiac 23 
patients undergoing cardiac rehabilitation, each 1 ml·kg-1·min-1 increase in VO2Peak was 24 
associated with a ∼15% decrease in all-cause mortality, meaning that this relatively modest 25 
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mean difference in VO2Peak improvement may still provide a protective mortality effect for 1 
the HIIT group 40. 2 
 3 
The studies that considered changes in VO2Peak for HIIT versus low-intensity groups provided 4 
conflicting results 31, 33. A short-term 8 week HIIT programme resulted in significantly 5 
greater improvements in VO2Peak compared with the low-intensity programme33. Conversely 6 
the longer six month programme led to significant but similar benefits in both the HIIT and 7 
low-intensity groups 31. As previously mentioned, the similar benefits obtained across both 8 
groups may have been obscured by the longer duration of the exercise programme. This lends 9 
us to believe that improvements in the HIIT group may have occurred much sooner but this 10 
was masked by the longer programme duration. This is evidenced by the fact that the lower 11 
intensity group were required to complete a longer duration of 3-5minutes per session, 12 
translating to an extra 9-15minutes per week and 4.6 hours over the course of the programme. 13 
 14 
A recent meta-analysis in patients with coronary artery disease demonstrated that HIIT 15 
significantly improved VO2Peak, with benefits being obtained in as little as four weeks 14. 16 
Furthermore, a recent study considered an eight week intervention of two low-volume HIIT 17 
protocols (<30minutes a week) versus a moderate-intensity continuous exercise protocol 18 
(76minutes a week) for previously sedentary individuals 19. The results showed that although 19 
all three groups demonstrated improvements in VO2Peak, the HIIT protocols induced a 4-11% 20 
greater improvement, required 60% less time commitment and had a substantially lower 21 
drop-out rate compared with the moderate intensity group 19. Similarly, in the study of 22 
Slørdahl et al (2005), included in this review, the HIIT group demonstrated a significant 23 
improvement in VO2Peak with an exercise time of just 16minutes per 40minute session, and a 24 
programme duration of eight weeks 33.These studies suggest that shorter-term, low volume 25 
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HIIT protocols may be beneficial to induce improvements in VO2Peak, thus again reducing 1 
patient burden and improving adherence. This needs to be evidenced in patients with PAD 2 
using randomised trials that consider shorter term, low volume HIIT programmes versus 3 
usual care exercise programmes.  4 
Quality of Life 5 
There was limited consideration of QoL amongst the included studies and was reported in 6 
just three. A six week upper or lower limb HIIT programme elicited significant improvement 7 
in the physical functioning and role limitation physical domains of the SF-36 28, whereas a 8 
longer, 24 week programme elicited a greater improvement in relation to controls in the 9 
majority of the SF-36 and WIQ domains 29, 30. Although this may suggest that longer HIIT 10 
programmes are more beneficial for improvements in QoL, a six month treadmill programme 11 
elicited more modest improvements, with significant changes only occurring in two SF-36 12 
domains and one WIQ domain 31. These equivocal results suggest that more research into the 13 
effects of HIIT on QoL would be beneficial in determining the true benefits of this exercise 14 
method. QoL should be included as an outcome measure in all future studies considering both 15 
HIIT and usual care SEP’s for the treatment of IC, as a recent Cochrane review of exercise 16 
for IC noted that QoL was only reported in two of the 32 included studies 10. 17 
 18 
Recruitment and adherence 19 
Only one study reported recruitment rates, which were slightly lower than that previously 20 
reported at 20% 13, 29. However, this may have been affected by the programme length of 6 21 
months. Therefore, it is important that future trials report the number of patients who were 22 
screened, to allow for identification of recruitment rates.  23 
However, completion rates were generally higher than the previously reported 75% for SEP’s 24 
13, with two studies reporting 100% completion rates in the exercise groups. In addition, 25 
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adherence rates for exercise sessions were reported in all but one study and were generally 1 
>90%. Only one study, which compared HIIT with low-intensity exercise, reported rates that 2 
were lower than this, but there was no significant difference between the two groups 31.  3 
It is also worth noting that the age of patients initially recruited and subsequently randomised 4 
to the HIIT or comparator groups was comparable to that previously reported for SEP’s 10. It 5 
is therefore unlikely that HIIT recruitment and adherence is influenced by age, nor is it 6 
preferred by a younger patient group.   7 
Therefore, considering these completion and adherence rates, that are at least comparable to 8 
SEP’s, it appears that HIIT is exceptionally well tolerated and acceptable in this population. 9 
Future Directions 10 
Although the results suggest that HIIT may provide improvements in walking distances, 11 
VO2Peak and QoL, five of the eight included studies compared HIIT with either unsupervised 12 
exercise advice or a sedentary control group, whilst all HIIT groups were supervised. Given 13 
that SEP’s are recommended as first line treatment in the UK and that intensity of supervision 14 
is related to improvements in walking distance, these groups may not provide a valid 15 
comparator 9, 41. Considering the overwhelming evidence for SEP’s it may be unsurprising 16 
that supervised HIIT is more beneficial than these comparator groups, suggesting that any 17 
exercise is better than none at all. In addition, there is a lack of standardisation with regards 18 
to the HIIT protocol, with varying modalities, intervals and intensities, though this is also the 19 
case for usual SEP’s despite the substantial evidence base 11, 12.  The data suggests that 20 
benefits between different HIIT modalities are comparable, which is congruent with SEP’s in 21 
the UK that adopt either aerobic exercise or aerobic exercise in combination with resistance 22 
training 12. The data also suggests that short-term HIIT can provide comparable benefits to 23 
longer-term protocols, but the most effective protocol is currently unknown. We therefore 24 
recommend that future randomised controlled trials (RCTs) use the most pragmatic modality 25 
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available and adopt short-term, low-volume HIIT at an appropriate intensity (i.e. ≥85% 1 
HRPeak) and tolerable interval (i.e. short work-to-rest ratio), in comparison to an appropriate 2 
control group (i.e. usual SEP’s), to provide a homogenous evidence base which can identify 3 
whether HIIT can accrue superior benefits or if it is indeed more time-efficient. Although this 4 
future evidence may show that short-term, low-volume HIIT is more time-efficient, it is 5 
important to recognise that it will still require a significant time commitment for patients. 6 
However, it is much less burdensome than current SEP’s and is therefore likely to be more 7 
attractive to patients, healthcare professionals, employers and insurance providers.  8 
 9 
There is also a lack of long-term follow-up for patients undergoing any form of exercise for 10 
IC in the literature. It is important that these patients are followed-up for longer periods to 11 
demonstrate and support self-monitored compliance with a healthy, active lifestyle following 12 
the initial intervention. We therefore recommend that any exercise trial in the IC population, 13 
especially the aforementioned RCTs, adopt a longer-term follow-up in the protocol (i.e. 1 and 14 
5 years). 15 
 16 
Limitations 17 
There are a number of limitations of this review that limit the conclusions that can be drawn 18 
from it. Firstly, most studies had unclear risk of bias for a number of criteria and also 19 
included small sample sizes, with one study recruiting only 13 patients. There was also 20 
considerable heterogeneity between studies with outcome measures differing between 21 
studies, especially with regards to walking distance which was recorded using both over 22 
ground and treadmill walking, whilst also being reported in different ways such as MWD or 23 
MWT. There is a need within the literature for a standardised protocol for testing and 24 
reporting walking distance in IC patients to allow for more comparable results. In addition, 25 
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the intervention protocols differed vastly between studies, in terms of the frequency, 1 
intensity, duration and type of exercise that was undertaken, making it difficult to implement 2 
a HIIT exercise programme in a real-world setting based upon findings from the current 3 
literature.  4 
 5 
 6 
 7 
Conclusion 8 
On the basis of the evidence in this review, HIIT cannot yet be incorporated into exercise 9 
management protocols for IC and the authors recommend that where possible, usual SEP’s 10 
continue to be provided. However, this review provides initial evidence to suggest that HIIT 11 
can elicit improvements in walking distances and VO2Peak whilst also potentially improving 12 
QoL in patients with IC. In addition, the completion and adherence rates suggest that HIIT is 13 
tolerable and acceptable in this population. HIIT may also provide the same symptomatic 14 
benefit to patients in a shorter duration, limiting the burden for both the patient and the 15 
provider. The results also suggest that these benefits are obtainable across a variety of 16 
different exercise modalities. 17 
At present however, there is insufficient evidence available to draw robust conclusions on the 18 
role of HIIT in IC patients due to the heterogeneity of the interventions and small sample 19 
sizes of the included studies. The heterogeneous data will also preclude accurate power 20 
calculations for future studies. Therefore, initial pilot RCTs comparing HIIT, designed based 21 
on our aforementioned recommendations, to usual SEP’s, including physical and QoL 22 
outcome measures, with longer-term follow-up are required. This will then allow for future 23 
RCT’s to be appropriately designed and adequately powered to further explore the potential 24 
benefits of HIIT protocols in the PAD population.    25 
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